Redo laparoscopic pyeloplasty for recurrent ureteropelvic junction obstruction: Propensity score matched analyses of a high-volume center

Jiayi Li, Yang Yang, Zonghan Li, Songqiao Fan, Xinyu Wang, Pei Liu, Hongcheng Song, Weiping ZhangFrontiers in Pediatrics 2022 · DOI

TL;DR

Redo laparoscopic pyeloplasty (RLP) is a safe and effective minimally invasive alternative to traditional open surgery for children with recurrent ureteropelvic junction obstruction (UPJO). While the procedure takes longer than a primary repair due to scar tissue, it offers significantly shorter hospital stays than open redo surgery while maintaining comparable success and complication rates.

What Problem Does This Paper Address?

Ureteropelvic junction obstruction (UPJO) is a common cause of pediatric hydronephrosis (kidney swelling). While primary laparoscopic pyeloplasty (PLP) is the gold standard for repair, it fails in up to 11% of cases.

When the first surgery fails, the "redo" is a significant surgical challenge. The area is typically encased in dense fibrotic scar tissue, and the anatomical landmarks are distorted. Historically, most surgeons reverted to Redo Open Pyeloplasty (ROP) to manage this complexity. This paper investigates whether a minimally invasive "redo" (RLP) is actually feasible and how its outcomes stack up against both primary repairs and the traditional open redo approach.

Methods

The researchers conducted a retrospective study at a high-volume center (Beijing Children’s Hospital) analyzing data from December 2015 to December 2022. To ensure a fair comparison between groups with different baseline characteristics, they used Propensity Score Matching (PSM).

The study compared three groups:

  1. RLP (Redo Laparoscopic): 10 patients.
  2. PLP (Primary Laparoscopic): 412 patients (matched 1:4 with RLP).
  3. ROP (Redo Open): 43 patients (matched 1:3 with RLP).

The team evaluated primary outcomes including surgical failure (re-obstruction) and post-operative complications classified by the Clavien-Dindo system. They also looked at secondary metrics like operation time and length of stay (LOS).

Datasets

The study utilized a clinical dataset of 504 total patients from the Department of Urology at Beijing Children’s Hospital. After applying strict exclusion criteria (e.g., patients with solitary kidneys, bilateral UPJO, or incomplete data), the final analysis focused on the cohorts mentioned above. No external or public benchmarks were used, as this is a clinical outcome study.

Key Insights and Ideas

  • The "Magnification Advantage": One of the most interesting takeaways is that laparoscopy might actually be better for redos because the camera provides a magnified view. This helps surgeons identify the "true" anatomical planes amidst the "messy" scar tissue (hyperplasia) that often causes the initial failure.
  • Why Redos Fail: The authors identified specific reasons for the primary surgery's failure during the redo procedures, including severe scar hyperplasia (50%), adhesions (20%), and even missed crossing vessels or polyps.
  • The Trade-off: RLP is technically demanding. The study confirms it takes significantly longer than a primary repair (median 158 mins vs. 110 mins) because the surgeon must meticulously "unstick" the kidney and ureter from surrounding scar tissue.
  • Recovery Efficiency: Despite the longer time on the operating table, RLP patients recovered much faster than ROP patients, highlighting the inherent benefits of minimally invasive access (smaller incisions, less tissue trauma).

Key Results

  • Success Rate: The RLP group achieved a 100% success rate (no failures) during the follow-up period (6–36 months).
  • RLP vs. PLP: After matching, RLP had a longer operation time ($P < 0.05$) and a slightly longer hospital stay ($P < 0.05$), but complication rates were statistically comparable.
  • RLP vs. ROP: RLP demonstrated a significantly shorter post-operative length of stay (6 days vs. 10 days, $P = 0.003$).
  • Clinical Improvement: All RLP patients showed significant improvement in ultrasound markers, specifically a decrease in the anteroposterior diameter (APD) of the kidney and an improved ratio of pelvic size to cortical thickness.

Limitations and Future Work

The most significant limitation is the small sample size of the RLP group (n=10). Because recurrent UPJO is relatively rare, it is difficult to gather massive cohorts. Additionally, the study is retrospective, which introduces potential selection bias (though PSM helps mitigate this).

The authors suggest that while RLP is an excellent alternative, it requires "experienced hands." Future work should involve multi-center prospective randomized controlled trials with larger cohorts and longer follow-up periods to definitively establish RLP as the new standard of care for recurrent cases.

Summary updated

Abstract

Our result demonstrated that RLP performed as well as PLP except for a longer operation time. Compared with ROP, RLP has the advantages of a clearer surgical view, sufficient exposure, clearer anatomical landmark position, and minor trauma with a comparable clinical outcome. On experienced hands, RLP for recurrent UPJO after is a safe and effective procedure and should be considered an excellent alternative to the more commonly recommended ROP in select patients.
BibTeX
@inproceedings{li2022redo,
  author = {Jiayi Li and Yang Yang and Zonghan Li and Songqiao Fan and Xinyu Wang and Zhenzhen Yang and Pei Liu and Hongcheng Song and Weiping Zhang},
  title = {{Redo laparoscopic pyeloplasty for recurrent ureteropelvic junction obstruction: Propensity score matched analyses of a high-volume center}},
  booktitle = {Frontiers in Pediatrics},
  year = {2022},
  doi = {10.3389/fped.2022.997196},
}
Figure